期刊论文详细信息
The Japanese Journal of Pharmacology
Effects of KCA-098 on Bone Metabolism: Comparison with Those of Ipriflavone
Arao Ujiie1  Masami Kojima1  Hiroyoshi Endo2  Hideo Nagata1  Naoyuki Tsutsumi1  Kohtaro Kawashima2  Junko Tsuyuki1  Fumiaki Itoh1  Nobuhiko Arai1 
[1] Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.;Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University
关键词: KCA-098;    Ipriflavone;    Bone resorption;    Bone formation;    Ovariectomy;   
DOI  :  10.1254/jjp.65.343
学科分类:药理学
来源: Nihon Yakuri Gakkai Henshuubu / Japanese Pharmacological Society
PDF
【 摘 要 】

References(17)Cited-By(9)We previously found that 3, 9-bis(N, N-dimethylcarbamoyloxy)-5H-benzofuro[3, 2-c]quinoline-6-one (KCA-098) inhibited bone resorption in organ culture. In this study, to determine if KCA-098 is therapeutically applicable for the treatment of osteoporosis, we compared the effect of KCA-098 on bone tissues with that of ipriflavone, a drug that is clinically used for the treatment of osteoporosis. Both KCA-098 and ipriflavone inhibited parathyroid hormone-, prostaglandin E2-, 1α, 25-dihydroxyvitamin D3- and interleukin 1β-induced bone resorption of fetal rat bones, but the inhibitory activity of KCA-098 was more potent than that of ipriflavone. In fact, the effective concentrations of KCA-098 were 10 to 100 times lower than those of ipriflavone. Oral administration of KCA-098 (1 and 3 mg/kg) or ipriflavone (100 mg/kg) to ovariectomized rats on a low-calcium diet increased the breaking force and bone density of the femora, indicating that KCA-098 is as effective on the whole animal as ipriflavone. Furthermore, KCA-098 increased the length and calcium content of 9-day chick embryonic femora cultured in vitro, whereas ipriflavone did not, suggesting that KCA-098 had a direct stimulatory effect on bone mineralization. Therefore, KCA-098 seems to be more potent than ipriflavone in stimulating bone tissue formation and may thus be expected to become a useful agent for the treatment of osteoporosis.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912080713721ZK.pdf 484KB PDF download
  文献评价指标  
  下载次数:20次 浏览次数:13次